- Previous Close
1.8300 - Open
1.8000 - Bid 1.8100 x 100
- Ask 2.2900 x 200
- Day's Range
1.7600 - 1.9400 - 52 Week Range
1.7510 - 21.2350 - Volume
102,063 - Avg. Volume
160,689 - Market Cap (intraday)
65.626M - Beta (5Y Monthly) 2.05
- PE Ratio (TTM)
-- - EPS (TTM)
-10.8300 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
17.62
Cibus, Inc., an agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. It focuses on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or linked to environmental challenges. Cibus, Inc. is headquartered in San Diego, California.
www.cibus.comRecent News: CBUS
View MorePerformance Overview: CBUS
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBUS
View MoreValuation Measures
Market Cap
62.34M
Enterprise Value
84.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.41
Price/Book (mrq)
0.68
Enterprise Value/Revenue
19.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-10.76%
Return on Equity (ttm)
-129.65%
Revenue (ttm)
4.26M
Net Income Avi to Common (ttm)
-251.39M
Diluted EPS (ttm)
-10.8300
Balance Sheet and Cash Flow
Total Cash (mrq)
14.43M
Total Debt/Equity (mrq)
37.09%
Levered Free Cash Flow (ttm)
-52M